Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Labcorp Holdings ( (LH) ) has issued an announcement.
On December 9, 2025, Labcorp Holdings announced that Mark Schroeder, the Executive Vice President and President of Diagnostics Laboratories and Chief Operations Officer, will retire on April 1, 2026. This announcement marks a significant leadership change for the company, potentially impacting its operational strategies and stakeholder relations.
The most recent analyst rating on (LH) stock is a Hold with a $290.00 price target. To see the full list of analyst forecasts on Labcorp Holdings stock, see the LH Stock Forecast page.
Spark’s Take on LH Stock
According to Spark, TipRanks’ AI Analyst, LH is a Outperform.
Labcorp Holdings demonstrates strong financial performance and strategic growth initiatives, particularly in the Diagnostics and Central Laboratories segments. While technical indicators suggest a bearish trend, the company’s focus on high-growth areas and technological innovation provides a positive outlook. Valuation metrics indicate the stock is fairly valued, with potential for growth if earnings continue to improve. Recent corporate events further support the company’s strategic direction.
To see Spark’s full report on LH stock, click here.
More about Labcorp Holdings
Labcorp Holdings operates in the healthcare industry, primarily providing diagnostics and laboratory services, with a focus on advancing health and improving lives through innovative medical testing solutions.
Average Trading Volume: 778,355
Technical Sentiment Signal: Strong Buy
Current Market Cap: $21.9B
See more insights into LH stock on TipRanks’ Stock Analysis page.